Department of Ophthalmology & Visual Science, Eye & ENT Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia, Chinese Academy of Medical Sciences and Shanghai Key Laboratory of Visual Impairment and Restoration (Fudan University), Shanghai, China.
PLoS One. 2022 Oct 14;17(10):e0276286. doi: 10.1371/journal.pone.0276286. eCollection 2022.
For primary angle-closure and angle-closure glaucoma, the fact that refractive error sometimes deviates from predictions after intraocular lens (IOL) implantation is familiar to cataract surgeons. Since controversy remains in the accuracy of IOL power calculation formulas, both traditional and network meta-analysis on formula accuracy were conducted in patients with primary angle-closure conditions.
A comprehensive literature search was conducted through Aug 2022, focusing on studies on intraocular lens power calculation in primary angle-closure (PAC) and primary angle-closure glaucoma (PACG). A systemic review and network meta-analysis was performed. Quality of studies were assessed. Primary outcomes were the mean absolute errors (MAE) and the percentages of eyes with a prediction error within ±0.50 diopiters (D) or ±1.00 D (% ±0.50/1.00 D) by different formulas.
Six retrospective studies involving 419 eyes and 8 formulas (Barrett Universal II, Kane, SRK/T, Hoffer Q, Haigis, Holladay I, RBF 3.0 and LSF) were included. SRK/T was used as a reference as it had been investigated in all the studies included. Direct comparison showed that none of the involved formula outperformed or was defeated by SRK/T significantly in terms of either MAE or % ±0.50/1.00 D (all P>0.05). Network comparison and ranking possibilities disclosed BUII, Kane, RBF 3.0 with statistically insignificant advantage. No significant publication bias was detected by network funnel plot.
No absolute advantage was disclosed among the formulas involved in this study for PAC/PACG eyes. Further carefully designed studies are warranted to evaluate IOL calculation formulae in this target population.
Registration: PROSEPRO ID: CRD42022326541.
对于原发性闭角型青光眼和闭角型青光眼,白内障手术医生都知道,在眼内晶状体(IOL)植入后,屈光不正有时会偏离预测值。由于 IOL 屈光力计算公式的准确性仍存在争议,因此对原发性闭角型青光眼患者的公式准确性进行了传统和网络荟萃分析。
通过 2022 年 8 月进行全面的文献检索,重点研究原发性闭角(PAC)和原发性闭角型青光眼(PACG)的 IOL 屈光力计算。进行了系统评价和网络荟萃分析。评估研究质量。主要结局指标为不同公式的平均绝对误差(MAE)和预测误差在±0.50 屈光度(D)或±1.00 D(%±0.50/1.00 D)内的眼数百分比。
纳入了 6 项回顾性研究,共 419 只眼和 8 种公式(Barrett Universal II、Kane、SRK/T、Hoffer Q、Haigis、Holladay I、RBF 3.0 和 LSF)。由于所有纳入的研究都调查了 SRK/T,因此将其作为参考公式。直接比较显示,在 MAE 或%±0.50/1.00 D 方面,没有一种纳入的公式明显优于或劣于 SRK/T(均 P>0.05)。网络比较和排名可能性显示 BUII、Kane、RBF 3.0 具有统计学上无显著优势。网络漏斗图未检测到显著的发表偏倚。
在这项研究中,没有一种公式在 PAC/PACG 眼中具有绝对优势。需要进一步精心设计研究来评估该目标人群中的 IOL 计算公式。
PROSPERO 注册号:CRD42022326541。